RESUMO
Aiming at evaluating the possible adverse effects of the use of radiotherapy on the CNS in children, we studied fourteen patients in whom it was used: seven as part of the conventional prophylaxis we use in malignant lymphoproliferative processes (group I) and the remaining seven as a treatment for primary cerebral tumors (group II). We evaluated growth during periods ranging from 1.5 to 11 years, and also hypothalamic-pituitary function by RIA. We comment on the results and confirm the endocrine alterations, especially the deficit of growth hormone.
Assuntos
Neoplasias Encefálicas/radioterapia , Desenvolvimento Infantil/fisiologia , Sistema Hipotálamo-Hipofisário/efeitos da radiação , Transtornos Linfoproliferativos/radioterapia , Crânio/efeitos da radiação , Neoplasias Encefálicas/fisiopatologia , Criança , Pré-Escolar , Feminino , Humanos , Sistema Hipotálamo-Hipofisário/fisiopatologia , Lactente , Leucemia Linfocítica Crônica de Células B/fisiopatologia , Leucemia Linfocítica Crônica de Células B/radioterapia , Linfoma não Hodgkin/fisiopatologia , Linfoma não Hodgkin/radioterapia , Transtornos Linfoproliferativos/fisiopatologia , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/fisiopatologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/radioterapia , Radioterapia/efeitos adversosRESUMO
Authors report their brain computerized axial tomography findings (CAT) and intellectual performance, in fourteen children treated with cranial radiotherapy either as part of conventional prophylaxis with intrathecal methotrexate use in malignant lymphoproliferative processes or as treatment for a primitive cerebral tumor. They comment on myelinating leukoencephalopathy and neuropsychologic sequelae that can appear.